TRAIL/Apo-2 Ligand Induces Primary Plasma Cell Apoptosis
Authors:
Open Access
- 15 November 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 169 (10) , 5505-5513
Abstract
Apoptosis constitutes the primary mechanism by which noncycling plasma cells are eliminated after the secretion of Ag-specific Abs in a humoral immune response. The underlying mechanism is not known. Here, we demonstrate that the expression of both TRAIL/Apo-2 ligand and the death receptors (DR) DR5 and DR4, but not Fas, are sustained in IL-6-differentiated Ig-secreting human plasma cells as well as primary mouse plasma cells generated in a T-dependent immune response. Plasma cell apoptosis is induced by both endogenous and exogenous TRAIL ex vivo, suggesting that TRAIL-mediated killing may, in part, be plasma cell autonomous. By contrast, resting and activated B cells are resistant to TRAIL killing despite comparable expression of TRAIL and DRs. The preferential killing of plasma cells by TRAIL correlates with decreased expression of CD40 and inactivation of NF-κB. These results provide the first evidence that primary plasma cells synthesize TRAIL and are direct targets of TRAIL-mediated apoptosis, which may relate to the inactivation of the NF-κB survival pathway.Keywords
This publication has 57 references indexed in Scilit:
- TrueLeukemia, 1999
- Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors Signal NF-κB and JNK Activation and Apoptosis through Distinct PathwaysJournal of Biological Chemistry, 1999
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- TRAIL/Apo-2-ligand-induced apoptosis in human T cellsEuropean Journal of Immunology, 1998
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Fas ligation induces apoptosis of CD40-activated human B lymphocytes.Journal of Experimental Medicine, 1995
- The Role of Interleukin-6 in Mucosal IgA Antibody Responses in VivoScience, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Distinct short‐lived and long‐lived antibody‐producing cell populationsEuropean Journal of Immunology, 1986